文献速递小儿眼科与斜弱视眼底病与葡萄膜炎

IMI近视及其进展预防解读

IMI Prevention of Myopia and Its Progression.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

国际近视研究所(IMI)指出东亚和东南亚近视患病率显著上升,病理性近视并发症已成不可逆盲常见原因;基于人群与干预研究,增加学龄儿童户外时间是降低近视发生的重要策略,低浓度阿托品等临床措施可延缓进展。

要点

  • 鼓励学龄儿童增加户外时间是降低近视发生的重要策略,且安全性最高。
  • 低浓度阿托品(0.01%–0.05%)等临床措施可减缓近视进展,但需权衡风险获益。
  • 上述措施并非互斥,已开始被联合应用研究。

核心结论

  • 增加户外时间是降低近视发生的安全策略,低浓度阿托品、多焦眼镜、周边近视离焦接触镜和角膜塑形镜可减缓近视进展,需个体化权衡风险获益。

研究设计与样本

  • 依据已发表的人群基础研究与干预研究进行综述性总结,未报告具体检索范围与样本量。

主要发现

  • 东亚和东南亚近视患病率显著上升,近视性黄斑病变和高近视相关视神经病变是常见不可逆盲原因。
  • 增加学龄儿童户外时间被视为降低近视发生的重要策略,且相比其他措施最安全。
  • 低浓度阿托品(0.01%–0.05%)有轻度调节幅度下降、轻度瞳孔散大和过敏反应风险等副作用。

关键数值与推荐

  • 低浓度阿托品滴眼液浓度为0.01%至0.05%,可减少或减缓近视进展。
  • 多焦框架眼镜设计、产生周边近视离焦的接触镜可用于减缓近视进展。
  • 角膜塑形镜使用角膜透气硬镜夜间佩戴压平中央角膜、中周部变陡产生周边近视离焦以消除日间近视。

临床怎么用

  • 临床可建议学龄儿童增加户外活动时间,并根据年龄、健康和生活方式个体化选择低浓度阿托品、多焦眼镜、离焦接触镜或角膜塑形镜,并权衡风险获益。

局限性

  • 原文未报告具体检索范围、样本量、效应量及安全性数据,风险获益需结合个体情况判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of myopia has markedly increased in East and Southeast Asia, and pathologic consequences of myopia, including myopic maculopathy and high myopia-associated optic neuropathy, are now some of the most common causes of irreversible blindness. Hence, strategies are warranted to reduce the prevalence of myopia and the progression to high myopia because this is the main modifiable risk factor for pathologic myopia. On the basis of published population-based and interventional studies, an important strategy to reduce the development of myopia is encouraging schoolchildren to spend more time outdoors. As compared with other measures, spending more time outdoors is the safest strategy and aligns with other existing health initiatives, such as obesity prevention, by promoting a healthier lifestyle for children and adolescents. Useful clinical measures to reduce or slow the progression of myopia include the daily application of low-dose atropine eye drops, in concentrations ranging between 0.01% and 0.05%, despite the side effects of a slightly reduced amplitude of accommodation, slight mydriasis, and risk of an allergic reaction; multifocal spectacle design; contact lenses that have power profiles that produce peripheral myopic defocus; and orthokeratology using corneal gas-permeable contact lenses that are designed to flatten the central cornea, leading to midperipheral steeping and peripheral myopic defocus, during overnight wear to eliminate daytime myopia. The risk-to-benefit ratio needs to be weighed up for the individual on the basis of their age, health, and lifestyle. The measures listed above are not mutually exclusive and are beginning to be examined in combination.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Jonas JB, Ang M, Cho P, et al. IMI Prevention of Myopia and Its Progression. Invest Ophthalmol Vis Sci. 2021. PMID: 33909032. doi:10.1167/iovs.62.5.6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。